List of insiders holdings for NEUROCRINE BIOSCIENCES INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | ROBERTS BRYAN E 10% Owner |
2010-01-05 16:10:15 | 0 4,784,689 |
4,784,689 | Form 3/A |
2 | Hove Anders D 10% Owner |
2010-01-05 16:08:57 | 0 4,784,689 |
4,784,689 | Form 3/A |
3 | VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC Hove Anders D ROBERTS BRYAN E VHCP Management LLC 10% Owner |
2013-02-14 16:12:40 | 2,221,946 0 |
2,221,946 | Form 13G |
4 | GORMAN KEVIN CHARLES Director |
2025-02-14 18:57:31 | 551,775 0 |
551,775 | Form 4 |
5 | Gano Kyle Chief Executive Officer |
2025-02-14 18:20:05 | 276,128 0 |
276,128 | Form 4 |
6 | CAMPBELL D BRUCE Senior Vice President |
2003-05-27 17:31:27 | 223,704 0 |
223,704 | Form 4 |
7 | Coughlin Timothy P Chief Financial Officer |
2017-02-08 19:39:04 | 137,961 0 |
137,961 | Form 4 |
8 | RANIERI RICHARD J Sr. VP, Human Resources |
2008-02-29 17:16:06 | 130,000 0 |
130,000 | Form 4 |
9 | LYONS GARY A Director |
2024-08-15 17:21:58 | 119,047 0 |
119,047 | Form 4 |
10 | THOMAS CYNTHIA J VP, Human Resources |
2004-03-03 17:19:48 | 113,670 0 |
113,670 | Form 3 |
11 | BENEVICH ERIC Chief Commercial Officer |
2025-02-14 18:03:41 | 105,567 0 |
105,567 | Form 4 |
12 | ABERNETHY MATT Chief Financial Officer |
2025-02-14 18:00:12 | 101,739 0 |
101,739 | Form 4 |
13 | Lippoldt Darin Chief Legal Officer |
2025-02-14 18:26:10 | 99,045 0 |
99,045 | Form 4 |
14 | ROBERTS EIRY Chief Medical Officer |
2025-02-14 18:42:06 | 98,714 0 |
98,714 | Form 4 |
15 | Onyia Jude Chief Scientific Officer |
2025-02-14 18:35:09 | 96,479 0 |
96,479 | Form 4 |
16 | OBrien Christopher Flint Former Chief Medical Officer |
2018-02-07 18:08:56 | 65,196 0 |
65,196 | Form 4 |
17 | Cooke Julie Chief Human Resources Officer |
2025-02-14 19:13:07 | 62,561 0 |
62,561 | Form 4 |
18 | CONLON PAUL J Vice President Research (Biol) |
2003-12-18 13:56:15 | 0 57,335 |
57,335 | Form 4 |
19 | Boyer David W. Chief Corp. Affairs Officer |
2025-02-14 18:08:11 | 52,366 0 |
52,366 | Form 4 |
20 | Delaet Ingrid Chief Regulatory Officer |
2025-02-14 18:13:58 | 52,205 0 |
52,205 | Form 4 |
21 | VALEUR JENSEN MARGARET E EVP and General Counsel |
2011-09-01 17:27:30 | 50,000 0 |
50,000 | Form 4 |
22 | Lloyd-Smith Malcolm Chief Integration Officer |
2023-02-08 19:35:55 | 42,337 0 |
42,337 | Form 4 |
23 | RASTETTER WILLIAM H Director |
2024-08-16 17:00:51 | 37,491 0 |
37,491 | Form 4 |
24 | Grigoriadis Dimitri E. Chief Research Officer |
2022-02-02 20:04:40 | 37,065 0 |
37,065 | Form 4 |
25 | Gros David-Alexandre C President & COO |
2017-02-08 19:42:09 | 25,000 0 |
25,000 | Form 4 |
26 | MITCHELL W THOMAS Director |
2016-05-24 15:41:49 | 25,000 0 |
25,000 | Form 4/A |
27 | WIERENGA WENDALL EVP, Research & Development |
2006-01-23 20:15:00 | 25,000 0 |
25,000 | Form 4 |
28 | PAN HENRY Executive VP and CMO |
2005-06-06 13:35:43 | 22,000 0 |
22,000 | Form 4 |
29 | NEUROCRINE BIOSCIENCES INC Director |
2015-04-09 16:22:08 | 16,030 0 |
16,030 | Form 4 |
30 | STEINMAN LAWRENCE Director |
2005-03-02 14:24:21 | 15,500 0 |
15,500 | Form 4 |
31 | LITTLE ROBERT J SVP, Commercial Operations |
2005-02-22 17:19:47 | 15,000 0 |
15,000 | Form 4 |
32 | MOLLICA JOSEPH A Director |
2017-06-08 18:30:31 | 15,000 0 |
15,000 | Form 4 |
33 | VALE WYLIE W Director |
2011-05-25 19:13:39 | 15,000 0 |
15,000 | Form 4 |
34 | Nevinny Corinne H Director |
2018-05-25 19:56:48 | 12,500 0 |
12,500 | Form 4 |
35 | ADAMS ADRIAN Director |
2006-06-30 17:30:18 | 12,000 0 |
12,000 | Form 4 |
36 | SHERWIN STEPHEN A Director |
2025-02-14 18:49:28 | 10,673 0 |
10,673 | Form 4 |
37 | Sandrock Alfred Director |
2019-05-23 17:46:16 | 10,000 0 |
10,000 | Form 4 |
38 | Sharp Shalini Director |
2024-05-23 18:34:03 | 4,417 0 |
4,417 | Form 4 |
39 | POON CHRISTINE A Director |
2024-05-23 18:45:31 | 4,417 0 |
4,417 | Form 4 |
40 | Norwalk Leslie V Director |
2024-05-23 18:02:27 | 4,417 0 |
4,417 | Form 4 |
41 | Mercier Johanna Director |
2024-05-23 17:59:15 | 4,417 0 |
4,417 | Form 4 |
42 | Bozigian Haig P. Chief Development Officer |
2021-03-29 06:12:25 | 3,504 0 |
3,504 | Form 4/A |
43 | SAUNDERS JOHN Vice President Research (Chem) |
2003-12-19 14:48:22 | 2,916 0 |
2,916 | Form 4 |
44 | POPS RICHARD F Director |
2024-05-23 18:26:06 | 2,869 0 |
2,869 | Form 4 |
45 | MORROW GEORGE J Director |
2024-05-23 18:21:21 | 2,869 0 |
2,869 | Form 4 |
46 | HAWRAN PAUL W Senior Advisor |
2006-09-20 16:33:13 | 0 0 |
0 | Form 4 |
47 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
2013-02-14 15:26:39 | 0 0 |
0 | Form 13G |